Concepedia

Lailiang Qu

LQ

Statistics

Publications

20

Citations

641

H-Index

16

Active since

2016

Affiliations

State Key Laboratory of Natural Medicine(Current)

China Pharmaceutical University

Zhengzhou University

Xinyang Normal University

Shenyang Pharmaceutical University

Lailiang Qu is an author at State Key Laboratory of Natural Medicine specializing in drug discovery, pharmacology, and medicinal chemistry.

ORCID

Publications per year

2016–2024

20

Publications

20

Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA

Chéng Wáng, Lailiang Qu, Shang Li et al. · Journal of Medicinal Chemistry · 2021 · 100 citations · Full text

, , +14

Discovery of precision targeting EZH2 degraders for triple-negative breast cancer

Cheng Wang, Xinye Chen, Xingchen Liu et al. · European Journal of Medicinal Chemistry · 2022 · 59 citations

, , +14

Discovery of PT-65 as a highly potent and selective Proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer's disease

Lailiang Qu, Shang Li, Limei Ji et al. · European Journal of Medicinal Chemistry · 2021 · 51 citations · Full text

, , +12

Design, Synthesis, and Antifungal Activities of Novel Pyrazole-4-carboxamide Derivatives Containing an Ether Group as Potential Succinate Dehydrogenase Inhibitors

Bo Luo, Yacong Zhao, Jing Zhang et al. · Journal of Agricultural and Food Chemistry · 2023 · 48 citations

, , +14

Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer’s disease

Lailiang Qu, Limei Ji, Cheng Wang et al. · European Journal of Medicinal Chemistry · 2021 · 42 citations · Full text

, , +15

1–5 of 20